» Articles » PMID: 31002735

E6 Proteins from High-risk HPV, Low-risk HPV, and Animal Papillomaviruses Activate the Wnt/β-catenin Pathway Through E6AP-dependent Degradation of NHERF1

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2019 Apr 20
PMID 31002735
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

High-risk human papillomavirus (HPV) E6 proteins associate with the cellular ubiquitin ligase E6-Associated Protein (E6AP), and then recruit both p53 and certain cellular PDZ proteins for ubiquitination and degradation by the proteasome. Low-risk HPV E6 proteins also associate with E6AP, yet fail to recruit p53 or PDZ proteins; their E6AP-dependent targets have so far been uncharacterized. We found a cellular PDZ protein called Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) is targeted for degradation by both high and low-risk HPV E6 proteins as well as E6 proteins from diverse non-primate mammalian species. NHERF1 was degraded by E6 in a manner dependent upon E6AP ubiquitin ligase activity but independent of PDZ interactions. A novel structural domain of E6, independent of the p53 recognition domain, was necessary to associate with and degrade NHERF1, and the NHERF1 EB domain was required for E6-mediated degradation. Degradation of NHERF1 by E6 activated canonical Wnt/β-catenin signaling, a key pathway that regulates cell growth and proliferation. Expression levels of NHERF1 increased with increasing cell confluency. This is the first study in which a cellular protein has been identified that is targeted for degradation by both high and low-risk HPV E6 as well as E6 proteins from diverse animal papillomaviruses. This suggests that NHERF1 plays a role in regulating squamous epithelial growth and further suggests that the interaction of E6 proteins with NHERF1 could be a common therapeutic target for multiple papillomavirus types.

Citing Articles

Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis.

Wootton L, Morgan E Oncogene. 2025; 44(11):713-723.

PMID: 40011575 PMC: 11888991. DOI: 10.1038/s41388-025-03310-6.


E6AP is essential for the proliferation of HPV-positive cancer cells by preventing senescence.

Avenhaus A, Velimirovic M, Bulkescher J, Scheffner M, Hoppe-Seyler F, Hoppe-Seyler K PLoS Pathog. 2025; 21(2):e1012914.

PMID: 39919145 PMC: 11805377. DOI: 10.1371/journal.ppat.1012914.


Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.

Zhang Y, Qiu K, Ren J, Zhao Y, Cheng P Signal Transduct Target Ther. 2025; 10(1):44.

PMID: 39856040 PMC: 11760352. DOI: 10.1038/s41392-024-02083-w.


How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection.

Chen Y, Egawa N, Zheng K, Doorbar J Tumour Virus Res. 2025; 19:200313.

PMID: 39832674 PMC: 11847044. DOI: 10.1016/j.tvr.2025.200313.


The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy.

Li J, Ma Y, Wu Q, Ping P, Li J, Xu X Front Oncol. 2024; 14:1488730.

PMID: 39735605 PMC: 11671370. DOI: 10.3389/fonc.2024.1488730.


References
1.
Brimer N, Lyons C, Wallberg A, Vande Pol S . Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene. 2012; 31(43):4639-46. PMC: 3330202. DOI: 10.1038/onc.2011.589. View

2.
Massimi P, Shai A, Lambert P, Banks L . HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene. 2007; 27(12):1800-4. DOI: 10.1038/sj.onc.1210810. View

3.
Bello J, Nieva L, Paredes A, Gonzalez A, Zavaleta L, Lizano M . Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins. Viruses. 2015; 7(8):4734-55. PMC: 4576203. DOI: 10.3390/v7082842. View

4.
Reczek D, Berryman M, BRETSCHER A . Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol. 1997; 139(1):169-79. PMC: 2139813. DOI: 10.1083/jcb.139.1.169. View

5.
Miller A, Rosman G . Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989; 7(9):980-2, 984-6, 989-90. PMC: 1360503. View